key: cord-0935182-lw8i1gho authors: Sachinidis, Athanasios; Garyfallos, Alexandros title: COVID‐19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age‐associated B cells date: 2021-11-12 journal: Int J Rheum Dis DOI: 10.1111/1756-185x.14238 sha: a6adb88fc0019995a055caf12d3c42fd31d8160a doc_id: 935182 cord_uid: lw8i1gho nan Age-associated B cells (ABCs) constitute a CD11c + T-bet + B-cell population that expands continuously with age in healthy individuals, 1 but also displays a premature accumulation in cases of autoimmune and/or infectious diseases. [2] [3] [4] [5] In autoimmune settings, ABCs are implicated in the production of autoreactive immunoglobulin G, 2 the enhanced antigen presentation to T cells, and the formation of spontaneous germinal centers. 6, 7 T-bet, which is a transcription factor highly expressed in ABCs, is considered to be the master regulator of all these processes, 8 although new data suggest that its expression may not be required for the generation of functional ABCs. 9 In humans, the ABC subset is also known as double-negative (DN) B cells because of the lack of immunoglobulin D and CD27 memory marker expression. 10-12 DN B cells have been further divided into two subgroups, based on the expression of the follicular homing marker CXCR5. 13 More specifically, the CXCR5 + cells (DN1) are expanded in elderly healthy individuals and lack T-bet expression, whereas the CXCR5cells (DN2) express T-bet and are more marked in autoimmune diseases (mostly systemic lupus erythematosus). 10, 11, 13 The DN2 cells are hyperresponsive to Toll-like receptor 7 (TLR7) signaling, so are poised to generate autoreactive antibody-secreting plasmablasts. 13 In general though, their role in the development of autoimmunity remains elusive. Autoimmune disease flares and new-onset disease following coronavirus disease 2019 (COVID-19) vaccination have recently been reported. 14, 15 In general, all these cases appeared rare and most of them were moderate in severity and had an excellent resolution of inflammatory features, with the use of corticosteroids alone 14, 15 (indicating that COVID-19 vaccines are actually safe). The use of TLR7/8 and TLR9 agonists, as adjuvants of the available mRNA and DNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines, may be the trigger of these post-vaccination autoimmune/inflammatory phenomena, 14 as it is well known that both TLR7 and TLR9 are involved in the generation and amplification of autoreactive immune responses. 16 In more detail, the adjuvanticity of COVID-19 vaccines depends-to a large extent-on the intrinsic adjuvanticity of mRNA or DNA, which respectively stimulate the innate immune system through endosomal and cytoplasmic RNA/DNA sensors such as TLRs. 17 The stimulation of TLR7 and TLR9 might be expected to produce elevated levels of type I interferon and so upregulate interferon-stimulated genes 16, 17 that contribute to the pathogenesis of a number of rheumatic diseases. 18 Apart from autoimmune diseases, ABCs/DN B cells also expand in infectious diseases-including COVID-19, 4,5,19,20 usually having either an exhausted or anergic phenotype. 21 Moreover, circulating DN B cells increase in numbers after vaccination against influenza virus in healthy individuals. 22 Considering all these facts, we believe that there is a strong possibility for ABCs/DN B cells to be induced by COVID-19 vaccines and then be involved in the autoimmune phenomena that (may) follow. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity T-bet expressing B cells -novel target for autoimmune therapies? T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance T cell production of IFNγ in response to TLR7/IL-12 stimulates optimal B cell responses to viruses CD11c-expressing B cells are located at the T cell/B cell border in spleen and are potent APCs IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity B cells expressing the transcription factor T-bet drive lupus-like autoimmunity Generation of functional murine CD11c+ age-associated B cells in the absence of B cell T-bet expression A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two-dose SARS-CoV-2 messenger RNA vaccination. Arthritis Rheumatol Nucleic acid recognition receptors in autoimmunity COVID-19 vaccines: modes of immune activation and future challenges Type I interferon in rheumatic diseases Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIVinfected viremic individuals Specific induction of double negative B cells during protective and pathogenic immune responses Age-associated B cells Cutting edge: IL-4, IL-21, and IFN-γ interact to govern T-bet and CD11c expression in TLRactivated B cells Vaccination boosts protective responses and counters SARS-CoV-2-induced pathogenic memory B cells. medRxiv Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes Age-associated B cells (ABCs) in the prognosis, diagnosis and therapy of Systemic Lupus Erythematosus (SLE) Double negative (DN) B cells: a connecting bridge between rheumatic diseases and COVID-19?